Is Camurus AB (CAMRF) a Buy, Sell, or Hold?
OTC : CAMRF
Camurus AB
$58.51 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 113
- Market Capitalization
- $3.48B
- P/E Ratio
- 53.83
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $71.00
- Year Low
- $54.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $11.57
| Source | Headline |
|---|---|
|
Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
PDUFA target action date set to 18 December 2026 LUND, Sweden, July 17, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for CAM2029, octreotide extended-release injection, for the treatment of patients with acromegaly. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of 18 December 2026. prnewswire.com - 2026-07-17 01:22:00 |
|
Camurus AB (publ) (CAMRF) Q2 2026 Earnings Call Transcript
Camurus AB (publ) (CAMRF) Q2 2026 Earnings Call Transcript seekingalpha.com - 2026-07-15 12:47:58 |
|
Camurus' hormone disorder drug expected to be approved in 2027 after fresh FDA setback
Wall Street has pushed to next year expectations for a U.S. approval for Camurus' drug to treat a rare hormonal condition after the health regulator's second refusal on Wednesday. reuters.com - 2026-06-11 09:14:37 |
|
Camurus announces expansion of Lilly collaboration
LUND, Sweden, June 1, 2026 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that Eli Lilly and Company ("Lilly") has exercised its option to include amylin receptor agonists (amylin) in the collaboration and license agreement entered in June 2025. The decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal® technology for the development and commercialization of long acting cardiometabolic drug medicines to an additional compound class. prnewswire.com - 2026-06-01 11:33:00 |
|
Camurus AB (publ) (CAMRF) Q1 2026 Earnings Call Transcript
Camurus AB (publ) (CAMRF) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-12 15:20:49 |
